Find clinical trials for Heart Disease in Cincinnati, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Heart Disease trials near Cincinnati, OH, USA:
Atrial fibrillation is an abnormal beating of the heart that can lead to stroke or heart failure. Structural heart diseases...
Cincinnati, Ohio, United States and 2 other locations
non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart...
Cincinnati, Ohio, United States and 46 other locations
) application in patients with symptomatic heart disease due to failure of a surgical or transcatheter bioprosthetic aortic valve w...
Cincinnati, Ohio, United States and 107 other locations
study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blood flow through that part of the heart...
Cincinnati, Ohio, United States and 9 other locations
of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial).The study contains of 5 a...
Cincinnati, Ohio, United States and 50 other locations
open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in NYHA Class III Heart...
Cincinnati, Ohio, United States and 73 other locations
PumpKIN is a multicenter, prospective, single-arm feasibility study; Evaluating the investigational Jarvik 2015 VAD in pediatric patients with heart...
Early Phase 1
Cincinnati, Ohio, United States and 6 other locations
safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart...
Cincinnati, Ohio, United States and 67 other locations
Evaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defect
Cincinnati, Ohio, United States and 31 other locations
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...
Phase 3
Cincinnati, Ohio, United States and 39 other locations
Clinical trials
Research sites
Resources
Legal